SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-025245
Filing Date
2023-07-21
Accepted
2023-07-21 16:30:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 24497
2 formdefa14a_001.jpg GRAPHIC 8374
  Complete submission text file 0001493152-23-025245.txt   37360
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36268 | Film No.: 231102828
SIC: 2835 In Vitro & In Vivo Diagnostic Substances